GlassScriptPhysician profile
Lopa Shah
NPI 1801893292
$2,364.81
in general payments reported to CMS, 2019-2025
13 companies · $700 in 2025
The $700 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.12 · 2020: $132 · 2021: $125 · 2022: $207 · 2023: $439 · 2024: $732 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,870.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $919.90 | 2023-2025 | Stelara, Simponi Aria, Simponi |
| Qol Medical, LLC | $232.86 | 2023-2025 | Sucraid, Sucraid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $221.56 | 2022-2025 | Xifaxan, Trulance |
| Heron Therapeutics, INC. | $186.87 | 2022-2025 | Aponvie |
| Genzyme Corporation | $145.88 | 2022-2024 | |
| Eagle Pharmaceuticals, INC. | $133.28 | 2023 | |
| Merck Sharp & Dohme LLC | $127.05 | 2019-2020 | |
| Acelrx Pharmaceuticals, INC. | $125.00 | 2021 | |
| Becton, Dickinson and Company | $120.81 | 2024 | Phasix Mesh |
| Lilly USA, LLC | $82.54 | 2025 | Omvoh |
| Pacira Pharmaceuticals Incorporated | $34.96 | 2019-2020 | |
| Abbvie INC. | $17.31 | 2025 | |
| Ardelyx, INC. | $16.79 | 2023 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lopa Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.